Literature DB >> 20428309

The use of electroconvulsive therapy in atypical psychotic presentations: a case review.

John H Montgomery1, Devi Vasu.   

Abstract

Convulsive therapy and its progeny, electroconvulsive therapy (ECT), were originally used for the treatment of catatonic schizophrenia, and there is little doubt that ECT remains an effective intervention for the treatment of schizophrenia. However, current practice tends to favor the use of ECT in severe or treatment refractory affective disorders, and its use in schizophrenia and other nonaffective (atypical) psychotic disorders has become controversial.CASE REPORTS HAVE SUGGESTED A ROLE FOR ECT IN TWO SPECIFIC ATYPICAL PSYCHOTIC DISORDERS: Cotard's syndrome and cycloid psychosis. In this article, we review the atypical psychotic disorders and report a series of five case examples that signify the role of ECT in atypical psychotic presentations, particularly when the symptoms resemble those found in Cotard's syndrome and cycloid psychosis.

Entities:  

Keywords:  Cotard's syndrome; ECT; atypical psychotic disorders; cycloid psychosis; electroconvulsive therapy

Year:  2007        PMID: 20428309      PMCID: PMC2860524     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN: 1550-5952


  23 in total

1.  Relationship between cycloid psychosis and typical affective psychosis.

Authors:  J Cutting
Journal:  Psychopathology       Date:  1990       Impact factor: 1.944

Review 2.  Cycloid psychoses and schizoaffective psychoses--a comparison of different diagnostic classification systems and criteria.

Authors:  M Zaudig
Journal:  Psychopathology       Date:  1990       Impact factor: 1.944

3.  Epidemiology of cycloid psychosis.

Authors:  M Lindvall; O Hagnell; R Ohman
Journal:  Psychopathology       Date:  1990       Impact factor: 1.944

4.  Successful use of continuation electroconvulsive therapy in a case of late-onset Leonhard's confusion psychosis.

Authors:  Kazumasa Suzuki; Shuichi Awata; Junpei Suzuki; Hitoshi Iwasaki; Takehisa Takano; Hiroo Matsuoka
Journal:  J ECT       Date:  2005-12       Impact factor: 3.635

5.  Puerperal and cycloid psychoses. Results of a retrospective study.

Authors:  M Lanczik; J Fritze; H Beckmann
Journal:  Psychopathology       Date:  1990       Impact factor: 1.944

Review 6.  Schizophrenia and the structure of language: the linguist's view.

Authors:  Michael A Covington; Congzhou He; Cati Brown; Lorina Naçi; Jonathan T McClain; Bess Sirmon Fjordbak; James Semple; John Brown
Journal:  Schizophr Res       Date:  2005-04-02       Impact factor: 4.939

7.  A study of cycloid psychoses.

Authors:  C Perris
Journal:  Acta Psychiatr Scand Suppl       Date:  1974

8.  Cycloid psychoses: diagnosis and heuristic value.

Authors:  I F Brockington; C Perris; H Y Meltzer
Journal:  J Nerv Ment Dis       Date:  1982-11       Impact factor: 2.254

9.  Jules Cotard (1840-1889): his life and the unique syndrome which bears his name.

Authors:  J Pearn; C Gardner-Thorpe
Journal:  Neurology       Date:  2002-05-14       Impact factor: 9.910

10.  The Capgras and Cotard delusions.

Authors:  A W Young; K M Leafhead; T K Szulecka
Journal:  Psychopathology       Date:  1994       Impact factor: 1.944

View more
  6 in total

1.  Successful Resolution of Prominent Somatic Delusions Following Bi-temporal Electroconvulsive Therapy in a patient with Treatment-Resistant Schizoaffective Disorder.

Authors:  Joshua L Cohen; My-Hanh Thi Vu; Mirza Adam Beg; Soumya Sivaraman; Badari Birur
Journal:  Psychopharmacol Bull       Date:  2019-06-20

2.  Cotard's Syndrome in a Patient with Schizophrenia: Case Report and Review of the Literature.

Authors:  Jeff Huarcaya-Victoria; Mario Ledesma-Gastañadui; Maria Huete-Cordova
Journal:  Case Rep Psychiatry       Date:  2016-12-08

3.  Electroconvulsive Therapy in Functional Hallucination: Scope and Challenges.

Authors:  Sulochana Joshi; Rabi Shakya
Journal:  Case Rep Psychiatry       Date:  2017-10-17

4.  Does a Lack of Awareness of Cycloid Psychosis Hamper Adequate Treatment for Patients Suffering From This Disorder? A Case Report.

Authors:  Armand Hausmann; Julia Dehning; Michel Heil; Laurin Mauracher; Georg Kemmler; Heinz Grunze
Journal:  Front Psychiatry       Date:  2020-11-12       Impact factor: 4.157

5.  Investigation of Antidepressant Properties of Yohimbine by Employing Structure-Based Computational Assessments.

Authors:  Munazzah Tasleem; Abdulwahed Alrehaily; Tahani M Almeleebia; Mohammad Y Alshahrani; Irfan Ahmad; Mohammed Asiri; Nadiyah M Alabdallah; Mohd Saeed
Journal:  Curr Issues Mol Biol       Date:  2021-10-27       Impact factor: 2.976

6.  Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features.

Authors:  Ko Tsutsui; Takashi Kanbayashi; Keiko Tanaka; Shuken Boku; Wakako Ito; Jun Tokunaga; Akane Mori; Yasuo Hishikawa; Tetsuo Shimizu; Seiji Nishino
Journal:  BMC Psychiatry       Date:  2012-05-08       Impact factor: 3.630

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.